{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:55:36Z","timestamp":1789728936867,"version":"4.0.1"},"reference-count":52,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["CCCDI-UEFISCDI, PN-II-RU-TE-2014-4-0506, PN-III-P2-2.1-PED-2019-3552"],"award-info":[{"award-number":["CCCDI-UEFISCDI, PN-II-RU-TE-2014-4-0506, PN-III-P2-2.1-PED-2019-3552"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Atherosclerosis is the main cause of cardiovascular diseases with high prevalence worldwide. A promising therapeutic strategy to reverse atherosclerotic process is to improve the athero-protective potential of high-density lipoproteins (HDL). Since the small intestine is a source of HDL, we aimed to activate transcription of the endogenous HDL major proteins, apolipoprotein AI (ApoAI) and paraoxonase 1 (PON1), in enterocytes, and to evaluate their potential to correct the pro-inflammatory status of endothelial cells (EC). Caco-2 enterocytes were transfected with CRISPR activation plasmids targeting ApoAI or PON1, and their gene and protein expression were measured in cells and conditioned medium (CM). ATP binding cassette A1 and G8 transporters (ABCA1, ABCG8), scavenger receptor BI (SR-BI), and transcription regulators peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3), liver X receptors (LXRs), and sirtuin-1 (SIRT1) were assessed. Anti-inflammatory effects of CM from transfected enterocytes were estimated through its ability to inhibit tumor necrosis factor \u03b1 (TNF\u03b1) activation of EC. Transcriptional activation of ApoAI or PON1 in enterocytes induces: (i) increase of their gene and protein expression, and secretion in CM; (ii) stimulation of ABCA1\/G8 and SR-BI; (iii) upregulation of PPAR\u03b3, LXRs, and SIRT1. CM from transfected enterocytes attenuated the TNF\u03b1-induced inflammatory and oxidative stress in EC, by decreasing TNF receptor 1, monocyte chemoattractant protein-1, and p22phox. In conclusion, transcriptional activation of endogenous ApoAI or PON1 in enterocytes by CRISPR\/dCas9 system is a realistic approach to stimulate biogenesis and function of major HDL proteins which can regulate cholesterol efflux transporters and reduce the inflammatory stress in activated EC.<\/jats:p>","DOI":"10.3390\/biom11121769","type":"journal-article","created":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T22:19:16Z","timestamp":1638137956000},"page":"1769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CRISPR\/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction"],"prefix":"10.3390","volume":"11","author":[{"given":"Laura","family":"Toma","sequence":"first","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Barb\u0103lat\u0103","sequence":"additional","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M.","family":"Sanda","sequence":"additional","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-9085","authenticated-orcid":false,"given":"Loredan S.","family":"Niculescu","sequence":"additional","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca V.","family":"Sima","sequence":"additional","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia S.","family":"Stancu","sequence":"additional","affiliation":[{"name":"Lipidomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Townsend, N., Kazakiewicz, D., Lucy Wright, F., Timmis, A., Huculeci, R., Torbica, A., Gale, C.P., Achenbach, S., Weidinger, F., and Vardas, P. (2021). Epidemiology of cardiovascular disease in Europe. Nat. Rev. Cardiol.","DOI":"10.1038\/s41569-021-00607-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11892-019-1161-2","article-title":"Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors","volume":"19","author":"Jagannathan","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00441-008-0678-5","article-title":"Vascular endothelium in atherosclerosis","volume":"335","author":"Sima","year":"2009","journal-title":"Cell Tissue Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","article-title":"Endothelial cell metabolism in normal and diseased vasculature","volume":"116","author":"Eelen","year":"2015","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Little, P.J., Askew, C.D., Xu, S., and Kamato, D. (2021). Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship. Biomedicines, 9.","DOI":"10.3390\/biomedicines9060699"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X01206010078","article-title":"High Density Lipoprotein and it\u2019s Dysfunction","volume":"6","author":"Eren","year":"2012","journal-title":"Open Biochem. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2015.10.021","article-title":"HDL-A molecule with a multi-faceted role in coronary artery disease","volume":"452","author":"Arora","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"III-8","DOI":"10.1161\/01.CIR.0000131512.50667.46","article-title":"HDL cholesterol and protective factors in atherosclerosis","volume":"109","author":"Assmann","year":"2004","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.numecd.2014.05.009","article-title":"Resistance and intolerance to statins","volume":"24","author":"Reiner","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11883-017-0679-5","article-title":"Pharmacogenetics of Lipid-Lowering Agents: An Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies","volume":"19","author":"Messas","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s11886-012-0317-3","article-title":"Targeting high density lipoproteins in the prevention of cardiovascular disease?","volume":"14","author":"Larach","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: Vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"Luscher","year":"2014","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41598-017-07821-5","article-title":"Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients","volume":"7","author":"Carnuta","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00441-012-1437-1","article-title":"Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis","volume":"349","author":"Stancu","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1194\/jlr.R082313","article-title":"Is ABCA1 a lipid transfer protein?","volume":"59","author":"Phillips","year":"2018","journal-title":"J. Lipid. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4236\/abc.2012.23026","article-title":"Activation of peroxisome proliferator activated receptor-gamma results in an atheroprotective apolipoprotein profile in HepG2 cells","volume":"2","author":"Dahabreh","year":"2012","journal-title":"Adv. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.R083121","article-title":"Scavenger receptor B type 1: Expression, molecular regulation, and cholesterol transport function","volume":"59","author":"Shen","year":"2018","journal-title":"J. Lipid. Res."},{"key":"ref_23","first-page":"2290","article-title":"The protective role of Sirt1 in vascular tissue: Its relationship to vascular aging and atherosclerosis","volume":"8","author":"Kitada","year":"2016","journal-title":"Aging (Albany N. Y.)"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: Role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sanda, G.M., Toma, L., Barbalata, T., Moraru, O.E., Niculescu, L.S., Sima, A.V., and Stancu, C.S. (2021). Clusterin, paraoxonase 1 and myeloperoxidase alterations induce HDL dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus. Biofactors, in press.","DOI":"10.1002\/biof.1800"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Valanti, E.K., Dalakoura-Karagkouni, K., and Sanoudou, D. (2018). Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis. J. Pers. Med., 8.","DOI":"10.3390\/jpm8040034"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2040622316672544","article-title":"Ezetimibe: An update on its clinical usefulness in specific patient groups","volume":"8","author":"Hammersley","year":"2017","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCGENETICS.114.000952","article-title":"Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis","volume":"8","author":"Ross","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.10.010","article-title":"Therapeutic applications of reconstituted HDL: When structure meets function","volume":"157","author":"Darabi","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.21037\/cdt.2017.01.01","article-title":"Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: Rationale and design of the CARAT study","volume":"7","author":"Andrews","year":"2017","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11886-018-1004-9","article-title":"HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?","volume":"20","author":"Karalis","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_33","first-page":"500","article-title":"Effect of garlic extract on some serum biochemical parameters and expression of npc1l1, abca1, abcg5 and abcg8 genes in the intestine of hypercholesterolemic mice","volume":"50","author":"Mohammadi","year":"2013","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/biology4010017","article-title":"Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?","volume":"4","author":"Niesor","year":"2015","journal-title":"Biology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mnfr.201500422","article-title":"Hyperlipidemia-induced hepatic and small intestine ER stress and decreased paraoxonase 1 expression and activity is associated with HDL dysfunction in Syrian hamsters","volume":"59","author":"Stancu","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1900029","DOI":"10.1002\/mnfr.201900029","article-title":"Hyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger Extract","volume":"63","author":"Barbalata","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2017.09.012","article-title":"Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications","volume":"266","author":"Liu","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/abbs\/gms121","article-title":"Inhibitory effect of apolipoprotein A-I on matrix metalloproteinase-2 expression in vivo and in vitro","volume":"45","author":"Wang","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.21037\/atm-21-682","article-title":"Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_40","first-page":"5953","article-title":"From blood to gut: Direct secretion of cholesterol via transintestinal cholesterol efflux","volume":"16","author":"Vrins","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","article-title":"ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis","volume":"428","author":"Yu","year":"2014","journal-title":"Clin. Chim. Acta."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Fledderus, J., Vanchin, B., Rots, M.G., and Krenning, G. (2021). The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020103"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Robert, J., Osto, E., and von Eckardstein, A. (2021). The Endothelium Is Both a Target and a Barrier of HDL\u2032s Protective Functions. Cells, 10.","DOI":"10.3390\/cells10051041"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-021-00906-7","article-title":"APOA1: A Protein with Multiple Therapeutic Functions","volume":"23","author":"Cochran","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacbts.2017.11.004","article-title":"Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis","volume":"3","author":"Morton","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/ATVBAHA.116.308258","article-title":"Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis","volume":"37","author":"Wacker","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.119.039476","article-title":"Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation","volume":"140","author":"Barrett","year":"2019","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamacardio.2018.2112","article-title":"Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2018.2121","article-title":"Effect of Serial Infusions of CER-001, a Pre-beta High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/ATVBAHA.115.306827","article-title":"Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties","volume":"36","author":"Nguyen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/12\/1769\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:35:56Z","timestamp":1760168156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/12\/1769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["biom11121769"],"URL":"https:\/\/doi.org\/10.3390\/biom11121769","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}